Massachusetts Financial Services’s vTv Therapeutics VTVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-11,389
Closed -$1.85M 868
2018
Q1
$1.85M Buy
11,389
+117
+1% +$28.6K ﹤0.01% 707
2017
Q4
$2.71M Buy
11,272
+147
+1% +$33K ﹤0.01% 691
2017
Q3
$2.66M Buy
11,125
+66
+0.6% +$13.2K ﹤0.01% 685
2017
Q2
$2.2M Sell
11,059
-2
-0% -$417 ﹤0.01% 710
2017
Q1
$2.9M Sell
11,061
-17
-0.2% -$3.88K ﹤0.01% 687
2016
Q4
$2.14M Sell
11,078
-29
-0.3% -$6.67K ﹤0.01% 719
2016
Q3
$3.19M Buy
11,107
+114
+1% +$27.4K ﹤0.01% 692
2016
Q2
$2.55M Sell
10,993
-353
-3% -$81.2K ﹤0.01% 702
2016
Q1
$2.34M Buy
11,346
+144
+1% +$35.9K ﹤0.01% 696
2015
Q4
$3.05M Sell
11,202
-85
-0.8% -$23.9K ﹤0.01% 693
2015
Q3
$2.94M Buy
+11,287
New +$3.93M ﹤0.01% 702

Other funds holding VTVT

Massachusetts Financial Services's VTVT Position: Q2 2018 in Review

Massachusetts Financial Services sold out of vTv Therapeutics (VTVT) in Q2 2018, closing a stake of 11,389 shares — an estimated $1.85M sold.

Massachusetts Financial Services first reported a position in VTVT in Q3 2015 and held it in 11 quarters. The position peaked at $3.19M in Q3 2016. 27 funds tracked by Wall St. Rank hold VTVT as of Q2 2018.

  • Massachusetts Financial Services reported no remaining vTv Therapeutics position as of Q2 2018 after selling out during the quarter.
  • Massachusetts Financial Services sold 11,389 vTv Therapeutics shares in Q2 2018, an estimated $1.85M.
  • Massachusetts Financial Services first reported a position in vTv Therapeutics in Q3 2015 and held it in 11 quarters.
  • Massachusetts Financial Services's vTv Therapeutics position peaked at $3.19M in Q3 2016.
  • 27 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2018.

Based on Massachusetts Financial Services's 13F filing for Q2 2018, filed 30 Jul 2018.